FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

38112003: un (valeur de l'attribut)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
615211000077111 un (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
un est un(e) (attribut) modificateur adjectival général false Inferred relationship Some
un est un(e) (attribut) nombre true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
Mesalamine 1 g gastro-resistant and prolonged-release oral granules sachet Has presentation strength denominator value False un Inferred relationship Some 1
Mesalamine 1 g gastro-resistant and prolonged-release oral granules sachet Count of base of active ingredient False un Inferred relationship Some
Mesalamine 1 g gastro-resistant and prolonged-release oral granules sachet Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
Imiglucerase 400 unit powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Imiglucerase 400 unit powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Rifampin 600 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Rifampin 600 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Product containing precisely sermorelin (as sermorelin acetate) 50 microgram/1 ampule powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely sermorelin (as sermorelin acetate) 50 microgram/1 ampule powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely diazepam 500 microgram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely codeine phosphate 60 milligram and paracetamol 1 gram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely codeine phosphate 60 milligram and paracetamol 1 gram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely codeine phosphate 60 milligram and paracetamol 1 gram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) Has presentation strength numerator value (attribute) False un Inferred relationship Some 2
Remifentanil (as remifentanil hydrochloride) 1 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Remifentanil (as remifentanil hydrochloride) 1 mg powder for solution for injection vial Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
Remifentanil (as remifentanil hydrochloride) 1 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Lansoprazole 30 mg granules for gastro-resistant oral suspension sachet Count of base of active ingredient False un Inferred relationship Some
Lansoprazole 30 mg granules for gastro-resistant oral suspension sachet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely sodium fusidate 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely sodium fusidate 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Diazepam 2 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
Remifentanil (as remifentanil hydrochloride) 2 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Remifentanil (as remifentanil hydrochloride) 2 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Peginterferon alfa-2b 80 microgram powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Peginterferon alfa-2b 80 microgram powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely methadone hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Somatropin(rbe) 200 microgram powder for solution for injection syringe Count of base of active ingredient False un Inferred relationship Some
Somatropin(rbe) 200 microgram powder for solution for injection syringe Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely somatropin(rbe) 400 microgram/1 syringe powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely somatropin(rbe) 400 microgram/1 syringe powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Acetaminophen 500 mg and metoclopramide hydrochloride 5 mg effervescent powder for oral suspension sachet Has presentation strength denominator value False un Inferred relationship Some 2
Acetaminophen 500 mg and metoclopramide hydrochloride 5 mg effervescent powder for oral suspension sachet Has presentation strength denominator value False un Inferred relationship Some 1
Raltitrexed 2 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Raltitrexed 2 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Somatropin(rbe) 12 mg powder for solution for injection cartridge Count of base of active ingredient False un Inferred relationship Some
Somatropin(rbe) 12 mg powder for solution for injection cartridge Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely somatropin(rbe) 600 microgram/1 syringe powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely somatropin(rbe) 600 microgram/1 syringe powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely clonazepam 400 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Verteporfin 15 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Verteporfin 15 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely paracetamol 100 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely somatropin(rbe) 4 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely somatropin(rbe) 4 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely prednisolone 2 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely somatropin(rbe) 6 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely somatropin(rbe) 6 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely somatropin(rbe) 800 microgram/1 syringe powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely somatropin(rbe) 800 microgram/1 syringe powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Sulpiride 40 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Phenytoin 18 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
Product containing precisely somatropin(rbe) 1.2 milligram/1 syringe powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely somatropin(rbe) 1.2 milligram/1 syringe powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Oxybutynin chloride 1 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Product containing precisely triptorelin 11.25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely triptorelin 11.25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely spironolactone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Product containing precisely somatropin(rbe) 1.6 milligram/1 syringe powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely somatropin(rbe) 1.6 milligram/1 syringe powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely somatropin(rbe) 1.4 milligram/1 syringe powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely somatropin(rbe) 1.4 milligram/1 syringe powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Molgramostim 400 microgram powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Molgramostim 400 microgram powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Octreotide (as octreotide acetate) 30 mg powder for suspension for injection vial Count of base of active ingredient False un Inferred relationship Some
Octreotide (as octreotide acetate) 30 mg powder for suspension for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely phenobarbital 3 milligram/1 milliliter conventional release oral elixir (clinical drug) Count of base of active ingredient False un Inferred relationship Some
etoposide 100mg injection (pdr for recon) (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
etoposide 100mg injection (pdr for recon) (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Somatropin(rbe) 1.3 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Somatropin(rbe) 1.3 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely spironolactone 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Guar gum 5 g granules for oral suspension sachet Count of base of active ingredient False un Inferred relationship Some
Guar gum 5 g granules for oral suspension sachet Has presentation strength denominator value False un Inferred relationship Some 1
Prochlorperazine mesylate 5 mg effervescent oral granules sachet Has presentation strength denominator value False un Inferred relationship Some 1
Prochlorperazine mesylate 5 mg effervescent oral granules sachet Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ibuprofen 600 milligram/1 sachet granules for conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ibuprofen 600 milligram/1 sachet granules for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Glatiramer acetate 20 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Glatiramer acetate 20 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Spironolactone 10 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
Somatropin(rbe) 1.8 mg powder for solution for injection syringe Count of base of active ingredient False un Inferred relationship Some
Somatropin(rbe) 1.8 mg powder for solution for injection syringe Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely domperidone 1 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Spironolactone 1 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
Nitazoxanide 20 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Somatropin(rbe) 2 mg powder for solution for injection syringe Has presentation strength denominator value False un Inferred relationship Some 1

Start Previous Page 185 of 217 Next End


This concept is not in any reference sets

Back to Start